70 related articles for article (PubMed ID: 30016963)
1. E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia.
Liu Y; Chen P; Chen G; Chen X
Ann Hematol; 2023 Dec; 102(12):3345-3355. PubMed ID: 37665348
[TBL] [Abstract][Full Text] [Related]
2. GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy.
Liu Y; Liu Y; Chen P; Chen G; Chen X
Ann Hematol; 2024 Jun; 103(6):1967-1977. PubMed ID: 38676765
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine.
Assouline S; Gasiorek J; Bergeron J; Lambert C; Culjkovic-Kraljacic B; Cocolakis E; Zakaria C; Szlachtycz D; Yee K; Borden KLB
Haematologica; 2023 Nov; 108(11):2946-2958. PubMed ID: 36951168
[TBL] [Abstract][Full Text] [Related]
4. SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia.
Marrero RJ; Cao X; Wu H; Elsayed AH; Klco JM; Ribeiro RC; Rubnitz JE; Ma X; Meshinchi S; Aplenc R; Kolb EA; Ries RE; Alonzo TA; Pounds SB; Lamba JK
Blood Adv; 2023 Jun; 7(11):2538-2550. PubMed ID: 36689724
[TBL] [Abstract][Full Text] [Related]
5. Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia.
Jost F; Schalk E; Rinke K; Fischer T; Sager S
PLoS One; 2019; 14(7):e0204540. PubMed ID: 31260449
[TBL] [Abstract][Full Text] [Related]
6. Diffuse purpuric eruption in a patient with acute myeloid leukemia.
Momin ZK; Alame A; Vandergriff T; Thomas C; Nezafati K
JAAD Case Rep; 2023 Nov; 41():98-101. PubMed ID: 37920705
[No Abstract] [Full Text] [Related]
7. TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients.
Liu H; Chen P; Yang YL; Zhu KW; Wang T; Tang L; Liu YL; Cao S; Zhou G; Zeng H; Zhao XL; Zhang W; Chen XP
Eur J Pharmacol; 2021 Mar; 895():173894. PubMed ID: 33476656
[TBL] [Abstract][Full Text] [Related]
8. Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study.
Lu L; Luo L; Li X; Liu W; Wu B; Cai Q; Li J; Huang Y; Chen Y; Zheng Y; Hu J
Front Oncol; 2024; 14():1364834. PubMed ID: 38651155
[TBL] [Abstract][Full Text] [Related]
9. GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma.
Du Y; Ma Y; Zhu Q; Fu Y; Li Y; Zhang Y; Li M; Feng F; Yuan P; Wang X
Front Med; 2023 Feb; 17(1):119-131. PubMed ID: 36525138
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumour-infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma.
Lu J; Duan Y; Liu P; He X; Yang Y; Zhang R; Weng L
J Pathol; 2023 Jan; 259(1):21-34. PubMed ID: 36178315
[TBL] [Abstract][Full Text] [Related]
11. Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia.
Zhou FJ; Zeng CX; Kuang W; Cheng C; Liu HC; Yan XY; Chen XP; Zhou G; Cao S
J Cancer; 2021; 12(22):6727-6739. PubMed ID: 34659562
[No Abstract] [Full Text] [Related]
12. Epigenetics and microRNAs in UGT1As.
Meng CL; Zhao W; Zhong DN
Hum Genomics; 2021 May; 15(1):30. PubMed ID: 34034810
[TBL] [Abstract][Full Text] [Related]
13. Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients.
Yuan XQ; Chen P; Du YX; Zhu KW; Zhang DY; Yan H; Liu H; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Yang J; Zeng WJ; Chen XP
J Transl Med; 2019 Jul; 17(1):220. PubMed ID: 31291961
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients.
Wang S; Yuan X; Liu Y; Zhu K; Chen P; Yan H; Zhang D; Li X; Zeng H; Zhao X; Chen X; Zhou G; Cao S
J Transl Med; 2019 Mar; 17(1):101. PubMed ID: 30922329
[TBL] [Abstract][Full Text] [Related]
15. Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.
Osborne MJ; Coutinho de Oliveira L; Volpon L; Zahreddine HA; Borden KLB
J Mol Biol; 2019 Jan; 431(2):258-272. PubMed ID: 30428301
[TBL] [Abstract][Full Text] [Related]
16. Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens.
Chen P; Zhu KW; Zhang DY; Yan H; Liu H; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Yang J; Chen XP
J Transl Med; 2018 Jul; 16(1):197. PubMed ID: 30016963
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).
Zhu KW; Chen P; Zhang DY; Yan H; Liu H; Cen LN; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Chen XP
J Transl Med; 2018 Apr; 16(1):90. PubMed ID: 29631596
[TBL] [Abstract][Full Text] [Related]
18. UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy.
Díaz-Santa J; Rodríguez-Romanos R; Osca G; Pratcorona M; Garrido A; Coll R; Moret C; Escoda L; Tormo M; Heras I; Arnan M; Vives S; Salamero O; Lloveras N; Bargay J; Sampol A; Cruz D; Garcia A; Quiñones T; Esteve J; Sierra J; Gallardo D;
Leukemia; 2020 Nov; 34(11):2925-2933. PubMed ID: 32152464
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
